Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
teer decrease » mean decrease (Expand Search)
Showing 961 - 980 results of 13,275 for search '(( significant ((greater decrease) OR (teer decrease)) ) OR ( significant increase decrease ))', query time: 0.42s Refine Results
  1. 961
    The strength of the commute time-functional connectivity relationship demonstrates weak pathological significance and weak dependency on age.

    The strength of the commute time-functional connectivity relationship demonstrates weak pathological significance and weak dependency on age. by Rostam M. Razban (22232522)

    Published 2025
    Save to List
    Saved in:
  2. 962
    Restricted cubic spline plots showing the association between changes in PAL and risk of CVD.

    Restricted cubic spline plots showing the association between changes in PAL and risk of CVD. by Haiwei Li (282229)

    Published 2025
    Save to List
    Saved in:
  3. 963
    Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.

    Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 964
    Inequalities in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.

    Inequalities in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 965
    Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.

    Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 966
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 967
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 968
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 969
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 970
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 971
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 972
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 973
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 974
    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group.

    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 975
    RT-qPCR Primer.

    RT-qPCR Primer. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 976
    CCND1 is a target gene of miR-1247-3p.

    CCND1 is a target gene of miR-1247-3p. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 977
    miR-1247-3p was downregulated in CRC resistant cells.

    miR-1247-3p was downregulated in CRC resistant cells. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 978
    miR-1247-3p plasmid.

    miR-1247-3p plasmid. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 979
    RNA-sequencing data screening for miR-1247-3p target genes.

    RNA-sequencing data screening for miR-1247-3p target genes. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 980
    Dual luciferase primer.

    Dual luciferase primer. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: